Stock Comparison
CORT vs REGN
Corcept Therapeutics Incorporated and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$11.58B
$80.55B
P/E (TTM)
238.1
19.4
Forward P/E
54.4
17.1
Price/Sales
13.9
5.2
Price/Book
16.4
2.5
EV/EBITDA
1,274.7
13.1
Dividend Yield
—
0.45%
Profitability
Net Margin
6.61%
29.65%
Operating Margin
0.77%
24.32%
Return on Equity
8.23%
14.00%
Return on Assets
0.47%
6.53%
Growth (YoY)
Revenue Growth
31.70%
16.70%
Earnings Growth
24.10%
-4.50%
Price & Risk
Beta
0.5
0.2
52-Week High
$118.32
$810.12
52-Week Low
$32.15
$553.38
Analyst Target
$135.25
$833.54
Compare CORT and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.